MARKET

QDEL

QDEL

Quidel
NASDAQ
39.12
+0.86
+2.25%
After Hours: 39.98 +0.86 +2.20% 16:49 04/19 EDT
OPEN
38.19
PREV CLOSE
38.26
HIGH
39.47
LOW
37.78
VOLUME
1.11M
TURNOVER
0
52 WEEK HIGH
98.67
52 WEEK LOW
37.78
MARKET CAP
2.62B
P/E (TTM)
-258.7302
1D
5D
1M
3M
1Y
5Y
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
Barchart · 17h ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
Barchart · 1d ago
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
Barchart · 1d ago
QuidelOrtho Enters Oversold Territory (QDEL)
NASDAQ · 2d ago
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
Barchart · 2d ago
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
Barchart · 2d ago
Press Release: QuidelOrtho To Report First Quarter 2024 Financial Results
QuidelOrtho To Report First Quarter 2024 Financial Results on May 8, 2024. The company will report its financial results for its first quarter ended March 31, 2024, after the market close on Wednesday, May 8. A conference call will be held following the release of the financial results. Quidel ortho is a global provider of innovative in vitro diagnostic technologies.
Dow Jones · 2d ago
QuidelOrtho To Report First Quarter 2024 Financial Results
QuidelOrtho Corporation will report its financial results for its first quarter ended March 31, 2024, after the market close on May 8, 2024. The company will hold a conference call following the release of the financial results. Quidel ortho is a global provider of innovative in vitro diagnostic technologies.
Barchart · 2d ago
More
About QDEL
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Webull offers Quidelortho Corp stock information, including NASDAQ: QDEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QDEL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QDEL stock methods without spending real money on the virtual paper trading platform.